Using TEP-derived RNA profiles, Best et al. were able to successfully identify breast cancer in patients with an average accuracy of 62%; they also identified three subtypes (HER2+, PIK3CA, and triple-negative) [19]. This evidence concerns the gene PIK3CA and breast carcinoma.